Nokea
The intangible costs of drug therapy include:
- A. Loss of wages while undergoing therapy
- B. Inconvenience, pain, and suffering incurred with therapy
- C. Cost of medical equipment in the laboratory used to monitor therapeutic drug levels
- D. Cost of prescription drug coverage, such as Medicare Part D
Correct Answer: B
Rationale: Intangible costs are non-monetary, such as pain and suffering.
You may also like to solve these questions
Which of the following NSAIDs is a selective COX-2 inhibitor?
- A. Indomethacin
- B. Meloxicam
- C. Etoricoxib
- D. Mefenamic acid
Correct Answer: C
Rationale: Etoricoxib is a highly selective COX-2 inhibitor, reducing GI side effects compared to non-selective NSAIDs.
The patient asks the nurse why generic drugs would be used and voices concerns that only the brand name product will be safe. What is the nurses best response?
- A. Generic drugs are often less expensive.
- B. Some quality control problems have been found with generic drugs.
- C. Most generic drugs are very safe and can be cost effective as well.
- D. Although initial cost is higher for a brand name it may cost less in the long run.
Correct Answer: C
Rationale: Most generic medications are completely safe and may be identical to the brand name drug except generic medications are often less expensive, but this does not address the patients concern about safety. Although some quality control issues have occurred in the past, this does not address the patients concerns regarding safety or explain why generic drugs are prescribed and used. Although some doctors believe initial cost is higher but will cost less over time, this response also does not address the patients concerns.
A patient is prescribed lidocaine for ventricular arrhythmias. Which side effect should the nurse monitor for?
- A. Hypotension
- B. Nausea
- C. Seizures
- D. Bradycardia
Correct Answer: C
Rationale: Lidocaine, a Class IB antiarrhythmic, can cause CNS side effects like seizures at high doses, a key monitoring point.
When patients are started on darbepoetin alfa (Aranesp) they need monitoring of their blood counts to determine a dosage adjustment in:
- A. 6 weeks if they are a cancer patient
- B. 1 week if they have chronic renal failure
- C. 2 weeks if they are taking it for allogenic transfusion
- D. Each week throughout therapy
Correct Answer: A
Rationale: Cancer patients need blood count checks at 6 weeks for darbepoetin adjustment; renal patients adjust sooner, typically 2-4 weeks.
Angiotensin-converting enzyme inhibitors are useful in a variety of disorders. Which of the following statements are true about both its usefulness in the disorder and the reason for its use?
- A. Stable angina because it decreases the thickening of vascular walls due to decreased modified release.
- B. Heart failure because it reduces remodeling of injured myocardial tissues.
- C. Both 1 and 2 are true and the reasons are correct.
- D. Both 1 and 2 are true but the reasons are wrong.
Correct Answer: B
Rationale: ACE inhibitors reduce myocardial remodeling in heart failure; they are not used for stable angina.